Application | Comment | Organism |
---|---|---|
drug development | isozyme PFKFB4 appears to be a rational target for anti-neoplastic drug development | Homo sapiens |
medicine | pharmacological disruption of the PFKFB4 kinase domain may have clinical utility for the treatment of human cancers | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
additional information | stable shRNA knockdown of PFKFB4, silencing by siRNA and genomic deletion of PFKFB4 decrease fructose 2,6-bisphosphate. PFKFB4 overexpression increases fructose 2,6-bisphosphate and selective PFKFB4 inhibition in vivo markedly reduces fructose 2,6-bisphosphate, glucose uptake, and ATP levels | Homo sapiens |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mg2+ | required | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + beta-D-fructose 6-phosphate | Homo sapiens | - |
ADP + beta-D-fructose 2,6-bisphosphate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q16877 | gene/isozyme Pfkfb4 | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
A-549 cell | - |
Homo sapiens | - |
A-549 cell | PFKFB4 is overexpressed in human cancers | Homo sapiens | - |
colon | - |
Homo sapiens | - |
DU-145 cell | PFKFB4 is overexpressed in human cancers | Homo sapiens | - |
H-460 cell | - |
Homo sapiens | - |
HCT-116 cell | - |
Homo sapiens | - |
HCT-116 cell | PFKFB4 is overexpressed in human cancers | Homo sapiens | - |
leukocyte | - |
Homo sapiens | - |
LNCaP cell | - |
Homo sapiens | - |
LNCaP cell | PFKFB4 is overexpressed in human cancers | Homo sapiens | - |
lung | - |
Homo sapiens | - |
lung adenocarcinoma cell | overexpression of isozyme PFKFB4. PFKFB4 expression correlates with hypoxia in human lung adenocarcinoma xenografts | Homo sapiens | - |
MCF-7 cell | - |
Homo sapiens | - |
MCF-7 cell | PFKFB4 is overexpressed in human cancers | Homo sapiens | - |
additional information | isozyme PFKFB4 tissue expression analysis, overview | Homo sapiens | - |
NCI-H460 cell | PFKFB4 is overexpressed in human cancers | Homo sapiens | - |
ovary | - |
Homo sapiens | - |
pancreas | - |
Homo sapiens | - |
PC-3 cell | PFKFB4 is overexpressed in human cancers | Homo sapiens | - |
placenta | - |
Homo sapiens | - |
prostate | - |
Homo sapiens | - |
skeletal muscle | - |
Homo sapiens | - |
spleen | - |
Homo sapiens | - |
testis | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + beta-D-fructose 6-phosphate | - |
Homo sapiens | ADP + beta-D-fructose 2,6-bisphosphate | - |
? | |
additional information | recombinant human PFKFB4 kinase activity is 4.3-fold greater than its phosphatase activity | Homo sapiens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 | - |
Homo sapiens |
PFKFB4 | - |
Homo sapiens |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ATP | - |
Homo sapiens |
Organism | Comment | Expression |
---|---|---|
Homo sapiens | isozyme PFKFB4 is induced by hypoxia | up |
General Information | Comment | Organism |
---|---|---|
malfunction | PFKFB4 inhibition in H-460 cells reduces glycolytic flux to lactate and glutamate. PFKFB4 inhibition in H-460 cells increases apoptosis under normoxic and hypoxic conditions | Homo sapiens |
physiological function | isozyme PFKFB4 expressed in multiple transformed cells and tumors functions to synthesize fructose 2,6-bisphosphate, PFKFB4 is required for cancer cell survival during the metabolic response to hypoxia, presumably to enable glycolytic production of ATP when the electron transport chain is not fully operational. Isozyme PFKFB4 is overexpressed in human cancers, induced by hypoxia and required for survival and growth of several cancer cell lines | Homo sapiens |